...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>journal for immunotherapy of cancer >Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment
【24h】

Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment

机译：Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Prostate cancer (PC) has previously been established as a cold tumor and develops in an inert immunosuppressive environment. Current research focuses on altering the immune microenvironment of PC from cold to hot; thus, in the present review, the diverse roles of estrogen and estrogen receptor (ER) signaling was examined in the tumor cell and tumor immune microenvironment (TIM). We hypothesized that ER alpha promotes PC progression and ER beta impedes epithelial-mesenchymal transition in PC cells, while in the TIM, ER beta mediates the immunosuppressive environment, and low levels of ER alpha is associated with disease development. Selective estrogen receptor modulators (SERMs) or selective ER degraders play diverse roles in the regulation of ER isoforms. Patients with PC may benefit from the use of SERMs, including raloxifene, in combination with anti-PD1/PD-L1 checkpoint immunotherapy, or TGF-beta or Wnt antagonists. The present review demonstrated that immunotherapy-based strategies combined with SERMs may be an option for the future of PC-targeting therapy.

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号